# Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)

> **NCT02943785** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 1426 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Edoxaban-based Regimen
- **DRUG:** VKA-based Regimen

## Key facts

- **NCT ID:** NCT02943785
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-21
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 1426 (ACTUAL)
- **Last updated:** 2022-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02943785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02943785, "Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02943785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*